47 results
SC 14D9
EX-99
MOR
Morphosys AG
11 Apr 24
Tender offer solicitation
11:57am
with the Federal Trade Commission and the Department of Justice on 16 February 2024, and withdrawn and refiled on 4 March 2024. The second statutory waiting
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
-acquisition, at MorphoSys’ website at www.morphosys.com/en/investors/Novartis-TakeoverOffer, or by contacting MorphoSys’ investor relations department at +49 89 … or by contacting the Bidder’s investor relations department at the telephone number +41 61 324 7944.
Settlement:
With regard to the Tendered MorphoSys
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
Exhibit (a)(1)(H)
Form W-9 (Rev. March 2024) Request for Taxpayer Identification Number and Certification Department of the Treasury Internal … or nominee 14. Account with the Department of Agriculture in the name of a public entity (such as a state or local government, school district
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
-TakeoverOffer, or by contacting MorphoSys’ investor relations department at +49 89 89927 404.
MorphoSys Securityholders are urged to read this document
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
are available on the Bidder’s website at www.novartis.com/investors/morphosys-acquisition or by contacting the Bidder’s investor relations department at +41 61
6-K
EX-99.1
3qwng1 jl7y
20 Mar 24
Current report (foreign)
4:12pm
6-K
EX-99.1
723eytig3i79rp
13 Mar 24
Non-Financial Group Report 2023
4:12pm
6-K
EX-99.1
etonk t9oei9r534
13 Mar 24
Current report (foreign)
4:08pm
6-K
EX-99.3
88eisdgb1
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
SC14D9C
EX-99.9
yajegnqdh awb4s5
6 Feb 24
Written communication relating to third party tender offer
4:58pm
SC TO-C
EX-99.1
tmvdiir
6 Feb 24
Information about tender offer
4:52pm
SC TO-C
3nb5cel j3
6 Feb 24
Information about tender offer
4:52pm
SC TO-C
fr9cxs t5a
5 Feb 24
Information about tender offer
5:06pm
SC TO-C
EX-99.1
w0kty63hotfsng
5 Feb 24
Information about tender offer
5:06pm
SC TO-C
EX-99.2
8ta7xjn9i5mgwv8lt4sv
5 Feb 24
Information about tender offer
5:06pm
6-K
EX-99.2
no1ux7f6yq
11 Dec 23
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
11:26am
F-3ASR
EX-4.4
9vlgbj5i
16 Nov 23
Automatic shelf registration (foreign)
9:27am
6-K
EX-99.1
agnrmb8ezwo8
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
EX-99.1
7uv37xw
10 Aug 23
Half-Year Report JANUARY – JUNE 2023
8:51am